Shimon Slavin is a professor of medicine and scientific director of the International Center for Cell Therapy and Cancer Immunotherapy in Tel Aviv, Israel. He is currently serving as the medical and scientific director of Biotherapy International Center for Cancer Immunotherapy & Regenerative Medicine in Tel Aviv, Israe

Slavin pioneered the use of immunotherapy mediated by donor lymphocytes and innovative methods for stem cell transplantation for the cure of hematological malignancies and solid tumors, and more recently, the use of multi-potent stem cells for regenerative medicine. His development of new procedures based on clinical application of the most advanced basic science and biotechnology at the patient’s bedside attracts patients from all over the world.

He has written four books and more than 650 scientific publications and serves on many editorial boards and many national and international advisory boards. He has received many international awards in recognition of his excellence in basic science and clinical medicine, introducing new therapeutic concepts that paved the road for successful treatment of patients considered incurable by conventional medicine.

Health, Aspen Ideas, Healthcare, Policy, Gene Therapy Medicine, Science, Leadership,